Skip to main content

Table 5 Patient cutaneous and systemic adverse events

From: Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia

Patient Cutaneous adverse events Systemic adverse events
1 Grade 1 erythema; grade 2 skin ulceration None
2 Grade 2 skin ulceration Grade 1 anemia
3 Grade 1 skin ulceration None
4 Grade 2 skin ulceration Grade 2 ALT elevation; Grade 1 CK elevation
5 Grade 2 skin ulceration Grade 1 anemia
6 Grade 1 edema and swelling None
7 Grade 1 erythema and grade 1 tumor necrosis Grade 1 nausea; Grade 1 lethargy
\